XML 71 R42.htm IDEA: XBRL DOCUMENT v3.20.1
STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Details 1) - USD ($)
3 Months Ended 12 Months Ended
Nov. 30, 2018
Mar. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Number of Shares:        
Granted 600,000      
Weighted Average Exercise Price:        
Granted $ 0.37      
Weighted Average Remaining Contractual Term:        
Vested and Exercisable at December 31, 2019     8 months 12 days  
Stock Options [Member]        
Number of Shares:        
Balance, beginning   17,913,529 18,613,529 22,013,529
Granted   4,700,000 1,500,000 1,600,000
Exercised       (5,000,000)
Forfeited/cancelled     (2,200,000)  
Balance, ending   22,613,529 17,913,529 18,613,529
Exercisable   20,088,529    
Vested and Exercisable at December 31, 2019     16,913,529  
Weighted Average Exercise Price:        
Balance, beginning   $ 0.12 $ 0.14 $ 0.11
Granted   0.07 0.18 0.27
Exercised       0.07
Forfeited/cancelled     0.34  
Balance, ending   0.11 0.12 $ 0.14
Exercisable   $ 0.11    
Vested and Exercisable at December 31, 2019     $ 0.11  
Weighted Average Remaining Contractual Term:        
Balance at December 31, 2019     2 years 10 months 24 days  
Vested and Exercisable at December 31, 2019     2 years 9 months 18 days  
Aggregate Intrinsic Value:        
Vested at December 31, 2019     $ 60,000 [1] $ 2,113,368
Exercisable at December 31, 2019   $ 302 [2] $ 60,000 [1]  
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company's common stock for options that were in-the-money at each respective period. During the years ended December 31, 2019 and 2018, the aggregate intrinsic value of options exercised under the Company's stock option plans was $59,800 and $2,113,368, respectively.
[2] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company's common stock for options that were in-the-money at each respective period.